7.15

4.23% 0.29

Pre-market: 7.10 -0.05 -0.70%

Tilray Brands Inc (TLRY)

Overview News Price History Option Chain Financials Why TLRY Down? Discussions Forecast Stock Split

Tilray Brands Inc stock is traded at $7.15, with a volume of 5.09M. It is up +4.23% in the last 24 hours and up +15.14% over the past month. Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

Previous Close:

$6.86

Open:

$6.83

24h Volume:

5.09M

Relative Volume:

1.69

Market Cap:

$833.32M

Revenue:

$858.28M

Net Income/Loss:

$-1.34B

P/E Ratio:

-0.5234

EPS:

-13.6608

Net Cash Flow:

$-75.96M

1W Performance:

+6.40%

1M Performance:

+15.14%

6M Performance:

-54.46%

1Y Performance:

+58.89%

1-Day Range:

$6.81

$7.23

1-Week Range:

$6.72

$7.23

52-Week Range:

$3.507

$23.20

Tilray Brands Inc Stock (TLRY) Company Profile

Name

Tilray Brands Inc

Sector

Healthcare (1114)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

519.322.8800

Address

655 MADISON AVENUE, NEW YORK

Employee

2,842

Twitter

@tilray

Next Earnings Date

2026-04-01

Latest SEC Filings

TLRY's Discussions on Twitter

Compare TLRY vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLRY Tilray Brands Inc	7.15	799.52M	858.28M	-1.34B	-75.96M	-13.66
TAK Takeda Pharmaceutical Co Adr	17.55	56.30B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	122.72	51.46B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.68	43.42B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.02	37.73B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	573.44	25.79B	3.18B	1.33B	1.04B	27.90

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-02-26	Upgrade	Roth Capital	Neutral → Buy
Jan-27-26	Initiated	Canaccord Genuity	Hold
Apr-05-24	Reiterated	Alliance Global Partners	Neutral
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-29-22	Downgrade	The Benchmark Company	Hold → Sell
Mar-04-22	Upgrade	Canaccord Genuity	Hold → Buy
Nov-18-21	Initiated	Barclays	Underweight
Nov-01-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-11-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-03-21	Upgrade	Cantor Fitzgerald	Neutral → Overweight
May-11-21	Resumed	Cowen	Outperform
May-07-21	Resumed	Jefferies	Buy
May-06-21	Initiated	Canaccord Genuity	Buy
Apr-28-21	Resumed	BofA Securities	Buy
Feb-18-21	Downgrade	Piper Sandler	Overweight → Neutral
Feb-18-21	Downgrade	The Benchmark Company	Buy → Hold
Nov-16-20	Downgrade	Jefferies	Hold → Underperform
Nov-11-20	Downgrade	Stifel	Hold → Sell
Oct-01-20	Reiterated	MKM Partners	Neutral
Sep-21-20	Upgrade	Jefferies	Underperform → Hold
May-12-20	Reiterated	The Benchmark Company	Buy
Apr-16-20	Downgrade	Jefferies	Hold → Underperform
Apr-09-20	Downgrade	Consumer Edge Research	Overweight → Equal Weight
Feb-24-20	Downgrade	Cowen	Outperform → Market Perform
Jan-13-20	Initiated	BofA/Merrill	Neutral
Nov-13-19	Reiterated	The Benchmark Company	Buy
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Oct-22-19	Reiterated	Piper Jaffray	Overweight
Sep-20-19	Initiated	MKM Partners	Neutral
Aug-14-19	Reiterated	The Benchmark Company	Buy
Jul-17-19	Initiated	Ladenburg Thalmann	Neutral
Jun-28-19	Initiated	Consumer Edge Research	Overweight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Initiated	Oppenheimer	Perform
May-15-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
May-13-19	Initiated	Alliance Global Partners	Neutral

View All

Tilray Brands Inc Stock (TLRY) Latest News

Apr 20, 2026

Tilray Brands (NASDAQ:TLRY) Shares Up 4.2%Here's Why - MarketBeat

Apr 20, 2026

Tilray Brands Inc. stock rises Monday, outperforms market - MarketWatch

Apr 20, 2026

Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally? - Barchart

Apr 20, 2026

Top Cannabis Stocks To Watch TodayApril 20th - MarketBeat

Apr 20, 2026

Tilray shares jump as stock buying pressure builds - Traders Union

Apr 20, 2026

The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market - The Globe and Mail

Apr 20, 2026

On 4/20, Tilray says its medical cannabis business tops 400,000 patients - Stock Titan

Apr 20, 2026

Apr 19, 2026

Promising Cannabis Stocks To Follow NowApril 19th - MarketBeat

Apr 19, 2026

Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You - AOL.com

Apr 19, 2026

Apr 18, 2026

Analysts Adjust Tilray Brands Stock Ratings Following Sales Performance - HarianBasis.co

Apr 18, 2026

International Operations Offer Continued Strength to Tilray Brands (TLRY) - Insider Monkey

Apr 17, 2026

Is Tilray Brands, Inc. (TLRY) among the 11 best marijuana stocks to buy right now? - MSN

Apr 17, 2026

Tilray Brands Inc stock (US88832Q1067): Why international expansion is suddenly worth a closer look - AD HOC NEWS

Apr 17, 2026

Q3 2026 Tilray Brands Inc Earnings Call Transcript - GuruFocus

Apr 17, 2026

Q1 2026 Tilray Brands Inc Earnings Call Transcript - GuruFocus

Apr 17, 2026

Tilray Brands Inc (WBO:TLR2) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 17, 2026

Tilray Brands Inc (WBO:TLR2) Stock Earnings Transcripts - GuruFocus

Apr 17, 2026

Tilray Brands Inc (WBO:TLR2) Stock Price & 30 Year Financial Data - GuruFocus

Apr 17, 2026